Liens UNIL

FR EN

Unisciences

You are here: UNIL > Unisciences

Search
- Search
- Show the data
  from to

Giuseppe Pantaleo

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

434 publications

... | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1991 | 1990 | 1989 | ...

2010

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells.

Krieg C., Létourneau S., Pantaleo G., Boyman O., 2010. Proceedings of the National Academy of Sciences of the United States of America, 107 (26) pp. 11906-11911.

[DOI][WoS][Pmid][serval:BIB_8AF3B92A7DBD]

Improved immunogenicity against HIV-1 clade C antigens by using NYVAC-C with restored replication competence

Mooij P., Nieuwenhuis I., Beenhakker N., Hofman S., Esteban M., Jacobs B., Kibler K., Koopman G., Bogers W., Pantaleo G. et al., 2010. pp. A4-A5 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.

[WoS][serval:BIB_2937B153B472]

Improvement of the HIV/AIDS vaccine candidate NYVAC-C by deletion of the viral type I IFN inhibitor and/or acquisition of replication competence

Kibler K.V., Perdiguera B., Gomez C.E., Najera J.L., Gonzalez-Sanz R., Jimenez V., Quakkelaar E.D., Melief C.J., Haddad E., Sekaly R. et al., 2010. pp. A137 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.

[WoS][serval:BIB_2EA9BB35EA17]

Intrathecal immune responses to EBV in early MS.

Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G., Du Pasquier R.A., 2010. European Journal of Immunology, 40 (3) pp. 878-887. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_64ADB928ABD6]

Length variation in HIV-1 gp120 as the product of DNA misalignment mechanism

Guglietta Silvia, Pantaleo Giuseppe, Graziosi Cecilia, 2010. pp. P21 dans 16th International Symposium on HIV and Emerging Infectious Diseases, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_F25042414F74]

Lifelong dynamics of human CD4+CD25+ regulatory T cells: insights from in vivo data and mathematical modeling.

Baltcheva I., Codarri L., Pantaleo G., Le Boudec J.Y., 2010. Journal of Theoretical Biology, 266 (2) pp. 307-322.

[DOI][WoS][Pmid][serval:BIB_440F62F1B598]

Long sequence duplications, repeats, and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism.

Guglietta S., Pantaleo G., Graziosi C., 2010. Virology, 399 (1) pp. 167-175.

[DOI][WoS][Pmid][serval:BIB_E9335E404337]

Modulation of TCR avidity of primary HIV-1-specific CD8 T-cell responses by early and potent antiviral therapy responses

Harari A., Vlgano S., Bellutti Enders F., Cellerai C., Castro E., Cavassini M., Bart P., Pantaleo G., 2010. pp. A7-A8 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.

[WoS][serval:BIB_4ED69DA1DA17]

Natural killer cell receptor-repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.

Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. et al., 2010. Clinical Immunology, 137 (2) pp. 250-260.

[DOI][WoS][Pmid][serval:BIB_731757582EE2]

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial

Levy Y., Ellefsen K., Stoeehr W., Bart P., Lelievre J., Launay O., Wolf H., Weber J., Chene G., Pantaleo G., 2010. pp. A10 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.

[WoS][serval:BIB_C3AEE549A46C]

Poxvirus vector-based HIV vaccines.

Pantaleo G., Esteban M., Jacobs B., Tartaglia J., 2010. Current Opinion In Hiv and Aids, 5 (5) pp. 391-396.

[DOI][WoS][Pmid][serval:BIB_CEF989A6728D]

Prevalence of anti-HLA antibodies after liver transplantation.

Fontana M., Moradpour D., Aubert V., Pantaleo G., Pascual M., 2010. Transplant International, 23 (8) pp. 858-859.

[DOI][WoS][Pmid][serval:BIB_5D129DC921D7]

Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.

Cellerai C., Perreau M., Rozot V., Enders F.B., Pantaleo G., Harari A., 2010. Journal of Virology, 84 (8) pp. 3868-3878.

[DOI][WoS][Pmid][serval:BIB_241EC3C720DF]

Robust vaccine-elicited cellular immune responses in breast milk following systemic Simian Immunodeficiency Virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.

Wilks A.B., Christian E.C., Seaman M.S., Sircar P., Carville A., Gomez C.E., Esteban M., Pantaleo G., Barouch D.H., Letvin N.L. et al., 2010. Journal of Immunology, 185 (11) pp. 7097-7106.

[DOI][WoS][Pmid][serval:BIB_E8F437640A8A]

2009

Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells : P16-32

Cellerai C., Perreau M., Rozot V., Enders F. Bellutti , Bart P., Pantaleo G., Harari A., 2009. p. 261 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_6703D99F50F4]

Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?

Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Transplantation, 87 (12) pp. 1897-1898.

[DOI][WoS][Pmid][serval:BIB_B1BCD48E795C]

Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.

Mooij P., Balla-Jhagjhoorsingh S.S., Beenhakker N., van Haaften P., Baak I., Nieuwenhuis I.G., Heidari S., Wolf H., Frachette M.J., Bieler K. et al., 2009. Journal of Virology, 83 (11) pp. 5881-5889.

[DOI][WoS][Pmid][serval:BIB_BCE4CC57F51F]

Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines : OA021-01

Jacobs B., Kibler K., Wong S., Huynh T., Holechek S., Denzler K., Arndt W., Parrington M., Tartaglia J., Pantaleo G., 2009. pp. O13 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_C361DEFA7CC4]

Development of Elispot and CFSE flow cytometric assays for detecting beryllium sensitivity

Aubert Vincent, Poupon Lucienne, Medjitna-Rais Emmanuelle, Berode Michèle, Brutsche Martin, Lazor Romain, Bieler Gilles, Pantaleo Giuseppe, 2009. pp. 4S dans Joint Annual Meeting of the Swiss Respiratory Society, Swiss Society of Occupational Medicine, Swiss Paediatric Respiratory Society, Swiss Society for Thoracic Surgery, Davos (Switzerland), April 16/17, 2009, Swiss Medical Weekly. Peer-reviewed.

[serval:BIB_C0587E319949]

Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Harari A., Enders F.B., Cellerai C., Bart P.A., Pantaleo G., 2009. Journal of Virology, 83 (7) pp. 2862-2871.

[DOI][WoS][Pmid][serval:BIB_26C61DC56F12]

Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro : P17-23

Quakkelaar E., Redeker A., Loof N., Perdiguero B., Heinen P., Nieto J., Esteban M., Kibler K., Jacobs B., Pantaleo G. et al., 2009. p. 305 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_9FF37A338ADA]

IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.

Létourneau S., Krieg C., Pantaleo G., Boyman O., 2009. Journal of Allergy and Clinical Immunology, 123 (4) pp. 758-762. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_113F0F401E1A]

Immunologic and virologic characterization of an ART-treated HIV-I patients cohort with long-term control of viremia

Kinloch S., Cellerai C., Yerly S., Byrne P., Carroll A., Stauss H., Johnson A., Harari A., Pantaleo G., 2009. p. 277 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_BE5742C21373]

Increased EBV Reactivation in the Cerebrospinal Fluid of Patients with Early Multiple Sclerosis

Jaquiery E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G., Du Pasquier R.A., 2009. pp. 38-38 dans 9th International Symposium on NeuroVirology, Journal of Neurovirology. Peer-reviewed.

[WoS][serval:BIB_59CF5B9ABA09]

Indels in V4 share sequence features with insertions and deletions during somatic hypermutation of immunoglobulins : P20-20 LB

Guglietta S., Pantaleo G., Graziosi C., 2009. p. 424 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.

[DOI][WoS][serval:BIB_F13560C1279F]

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.

Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C.E., Perdiguero B., Tschopp J. et al., 2009. PLoS Pathogens, 5 (6) pp. e1000480.

[URN][DOI][WoS][Pmid][serval:BIB_C705291364B8]

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.

Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Human Immunology, 70 (8) pp. 580-583.

[DOI][WoS][Pmid][serval:BIB_C112FB3AA6A4]

Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.

Wild J., Bieler K., Köstler J., Frachette M.J., Jeffs S., Vieira S., Esteban M., Liljeström P., Pantaleo G., Wolf H. et al., 2009. Viral Immunology, 22 (5) pp. 309-319.

[DOI][WoS][Pmid][serval:BIB_EF5982B820CA]

The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level.

Belair M., Dovat M., Foley B., Mayerat C., Pantaleo G., Graziosi C., 2009. AIDS Research and Human Retroviruses, 25 (2) pp. 199-206.

[DOI][WoS][Pmid][serval:BIB_50C8746E0BA8]

Viral- and myelin-specific cellular immune response in patients treated with natalizumab: a cross-sectional and a longitudinal prospective study

Jilek Terrasse S., Lysandropoulos A., Jaquiery E., Canales M., Guignard L., Campiche C., Schluep M., Pantaleo G., Du Pasquier R.A., 2009. pp. 39-40 dans 9th International Symposium on NeuroVirology, Journal of Neurovirology. Peer-reviewed.

[WoS][serval:BIB_E707DC5E3521]

2008

A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.

Miconnet I., Pantaleo G., 2008. Vaccine, 26 (32) pp. 4006-4014. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_370F130E0147]

Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.

Perreau M., Pantaleo G., Kremer E.J., 2008. Journal of Experimental Medicine, 205 (12) pp. 2717-2725. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0F939F3B90DF]

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Harari A., Bart P. A., Stohr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T. et al., 2008. Journal of Experimental Medicine, 205 (1) pp. 63-77. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_3CD56A6881FB]

c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.

Brembilla N.C., Weber J., Rimoldi D., Pradervand S., Schütz F., Pantaleo G., Rüegg C., Quadroni M., Harshman K., Doucey M.A., 2008. Blood, 112 (3) pp. 652-660.

[DOI][WoS][Pmid][serval:BIB_6DDFA2713E61]

Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals.

Ehrhard S., Wernli M., Kaufmann G., Pantaleo G., Rizzardi G.P., Gudat F., Erb P., Battegay M., 2008. Infection, 36 (2) pp. 120-129. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_20524578AB68]

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

Bart P.A., Goodall R., Barber T., Harari A., Guimaraes-Walker A., Khonkarly M., Sheppard N.C., Bangala Y., Frachette M.J., Wagner R. et al., 2008. Vaccine, 26 (25) pp. 3153-3161. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CB078A5AF88C]

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.

McCormack S., Stöhr W., Barber T., Bart P.A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M., Gamboni R. et al., 2008. Vaccine, 26 (25) pp. 3162-3174. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6443A01EDC31]

HCV infection after liver transplantation is associated with lower levels of alloreactive CD4+CD25+CD45RO+IL-7R+high+ T cells

Ciuffreda Donatella, Codarri Laura, Buhler Leo, Giostra Emiliano, Mentha Gilles, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 389 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.

[WoS][serval:BIB_04AB1F93A528]

HIV-1 T-cell vaccines: evaluating the next step.

Pantaleo G., 2008. Lancet Infectious Diseases, 8 (2) pp. 82-83. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F91BBFE5C31F]

HIV-1-specific immune response.

Harari A., Pantaleo G., 2008. Advances in Pharmacology, 56 pp. 75-92.

[DOI][WoS][Pmid][serval:BIB_FFF7D277FB61]

Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants

Castro E., Belair M., Rizzardi G. P., Bart P. A., Pantaleo G., Graziosi C., 2008. AIDS Research and Human Retroviruses, 24 (1) pp. 106-113. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_83F70B875C65]

Insight in the factors associated with the presence of protective antiviral T-cell response.

Harari A., Bellutti Enders F., Garcia M., Pantaleo G., 2008. pp. 56-57 dans 2007 ESCCA Abstracts, Cytometry Part B: Clinical Cytometry. Peer-reviewed.

[DOI][serval:BIB_DA980B112D0D]

Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.

Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B. et al., 2008. European Journal of Immunology, 38 (10) pp. 2665-2677.

[DOI][WoS][Pmid][serval:BIB_1D7CF05887AD]

Prospective monitoring of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population after first kidney transplantation following thymoglobulin or basiliximab induction

Vallotton Laure, Hadaya Karine, Ciuffreda Donatella, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.

[WoS][serval:BIB_EE0E0B9DD549]

Prospective monitoring of a CD4+ CD25high CD45RO+ CD127high T-cell population after first kidney transplantation following thymoglobulin or basiliximab induction

Vallotton L., Hadaya K., Buhler L., Ciuffreda D., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_9C66A7A0B976]

Relationship between degranulation activity and content of granules in virus-specific CD8 T-cells : P39

Bellutti-Enders F., Harari A., Cellerai C., Pantaleo G., 2008. pp. 8S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_7DAE1AFF758E]

Relationship between HLA genotype and the functional profile of Ag-specific CD8 T-cells : 39

Harari A., Cellerai C., Bellutti-Enders F., Pantaleo G., 2008. pp. 47S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_743DD45FA7E0]

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.

Burton C.T., Goodall R.L., Samri A., Autran B., Kelleher A.D., Poli G., Pantaleo G., Gotch F.M., Imami N., 2008. Clinical and Experimental Immunology, 152 (2) pp. 252-257.

[DOI][WoS][Pmid][serval:BIB_97E9B91E59FD]

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis

Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G., Du Pasquier R.A., 2008. Brain, 131 (Pt 7) pp. 1712-1721. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_AF138C282868]

The presence of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population correlates with the clinical status of kidney transplant recipients

Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Hadaya Karine, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.

[WoS][serval:BIB_F81D421E7A36]

The presence of a CD4+ CD25high CD45RO+ CD127high T-cell population correlates with the clinical status of kidney transplant recipients

Vallotton L., Codarri L., Ciuffreda D., Hadaya K., Buhler L., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_7383265DF5F4]

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake D.R., Castro E. et al., 2008. Journal of Experimental Medicine, 205 (13) pp. 3119-3131.

[URN][DOI][WoS][Pmid][serval:BIB_E059A72A9FC1]

2007

Sequence analysis of the novel HLA-B35 (B*3576) allele in an African individual

Aubert V., Mayerat C., Lopez N., Pantaleo G., 2007/11. Tissue Antigens, 70 (5) pp. 439-41.

[DOI][WoS][Pmid][serval:BIB_44AD4941F1FC]

Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.

Jilek S., Kuhle J., Meylan P., Reichhart M.D., Pantaleo G., Du Pasquier R.A., 2007/10. Journal of Neuroimmunology, 192 (1-2) pp. 192-197. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D78D489A8FDD]

Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype

Harari A., Cellerai C., Enders F. B., Kostler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I. et al., 2007/10. Proceedings of the National Academy of Sciences of the United States of America, 104 (41) pp. 16233-8.

[DOI][WoS][Pmid][serval:BIB_B0591BC8253E]

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

Precopio M. L., Betts M. R., Parrino J., Price D. A., Gostick E., Ambrozak D. R., Asher T. E., Douek D. C., Harari A., Pantaleo G. et al., 2007/06. Journal of Experimental Medicine, 204 (6) pp. 1405-16.

[URN][DOI][WoS][Pmid][serval:BIB_D1AFA81DDA61]

Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization

Cellerai C., Harari A., Vallelian F., Boyman O., Pantaleo G., 2007/04. European Journal of Immunology, 37 (4) pp. 1129-38.

[DOI][WoS][Pmid][serval:BIB_5B3CE29EF5FA]

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B

Gomez C. E., Najera J. L., Jimenez E. P., Jimenez V., Wagner R., Graf M., Frachette M. J., Liljestrom P., Pantaleo G., Esteban M., 2007/04. Vaccine, 25 (15) pp. 2863-85.

[DOI][WoS][Pmid][serval:BIB_FB69A4A36EE9]

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

Gomez C. E., Najera J. L., Jimenez V., Bieler K., Wild J., Kostic L., Heidari S., Chen M., Frachette M. J., Pantaleo G. et al., 2007/03. Vaccine, 25 (11) pp. 1969-92.

[DOI][WoS][Pmid][serval:BIB_DC952B01F704]

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity

Peters B. S., Jaoko W., Vardas E., Panayotakopoulos G., Fast P., Schmidt C., Gilmour J., Bogoshi M., Omosa-Manyonyi G., Dally L. et al., 2007/03. Vaccine, 25 (11) pp. 2120-7.

[DOI][WoS][Pmid][serval:BIB_00D80A63BCAD]

CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.

Jilek S., Schluep M., Rossetti A.O., Guignard L., Le Goff G., Pantaleo G., Du Pasquier R.A., 2007. Clinical Immunology, 123 (1) pp. 105-113. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5B9811DBA8DB]

Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.

Ciuffreda D., Pantaleo G., Pascual M., 2007. Transplant International, 20 (8) pp. 649-658. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_692DE1D192A8]

Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.

Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M., Pantaleo G., 2007. Journal of Experimental Medicine, 204 (7) pp. 1533-1541. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_9F81B1648B01]

Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure

Correa R., Harari A., Vallelian F., Resino S., Munoz-Fernandez M. A., Pantaleo G., 2007/01. AIDS, 21 (1) pp. 23-30.

[DOI][WoS][Pmid][serval:BIB_C9782122B74A]

Identification of an expanded population of activated CD4(+) CD25(+) T cells expressing CD45RO and IL-7R in kidney transplant recipients

Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2007. p. 153 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.

[WoS][serval:BIB_272BEC140FF2]

Identification of an expanded population of activated CD4(+)CD25(+)CD45RO(+)IL-7R(+) T cells in liver transplant recipients: downmodulation by HCV

Ciuffreda D., Codarri L., Pascual M., Pantaleo G., 2007. pp. 18S dans Annual Conference Swiss Society for Allergology and Immunology, Spring Meeting Swiss Society of Dermatology and Venerology, Swiss Medical Weekly. Peer-reviewed.

[WoS][serval:BIB_F825F42C4AB3]

Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease

Samri A., Goodall R., Burton C., Imami N., Pantaleo G., Kelleher A., Poli G., Gotch F., Autran B., 2007. Antiviral Therapy, 12 (4) pp. 553-8.

[WoS][Pmid][serval:BIB_CC8034691E0F]

2006

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases

Pantaleo G., Harari A., 2006/05. Nature Reviews. Immunology, 6 (5) pp. 417-23.

[DOI][WoS][Pmid][serval:BIB_E848347E6AAF]

Metal-support interaction and redox behavior of Pt(1 wt %)/Ce0.6Zr0.4O2.

Deganello G., Giannici F., Martorana A., Pantaleo G., Prestianni A., Balerna A., Liotta L.F., Longo A., 2006/05. Journal of Physical Chemistry. B, 110 (17) pp. 8731-8739. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9F4D31EFE87A]

Immune-based interventions in HIV infection: doing the right studies, getting the right answers

Bart P. A., Pantaleo G., 2006/02. AIDS, 20 (4) pp. 617-8.

[DOI][WoS][Pmid][serval:BIB_43999594B92F]

Clinical studies of experimental vaccines.

Bart P.A., Harari A., Pantaleo G., 2006. Current Opinion in Hiv and Aids, 1 (4) pp. 286-293.

[DOI][WoS][Pmid][serval:BIB_E8922002E905]

Functional signatures of protective antiviral T-cell immunity in human virus infections.

Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., Pantaleo G., 2006. Immunological Reviews, 211 pp. 236-254. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FE2B6D903135]

Role of HIV-1-specific CD4 T cells.

Harari A., Cellerai C., Pantaleo G., 2006. Current Opinion In Hiv and Aids, 1 (1) pp. 22-27.

[DOI][WoS][Pmid][serval:BIB_AF649A5F6C06]

2005

Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection

Dutoit V., Ciuffreda D., Comte D., Gonvers J. J., Pantaleo G., 2005/12. European Journal of Immunology, 35 (12) pp. 3493-504.

[DOI][WoS][Pmid][serval:BIB_9ADA2E5F336F]

Understanding what makes a good versus a bad vaccine

Harari A., Pantaleo G., 2005/09. European Journal of Immunology, 35 (9) pp. 2528-31.

[DOI][WoS][Pmid][serval:BIB_FE51441F1B0A]

A new cell for the study of in situ chemical reactions using X-ray absorption spectroscopy.

Longo A., Balerna A., d'Acapito F., D'Anca F., Giannici F., Liotta L.F., Pantaleo G., Martorana A., 2005/07. Journal of Synchrotron Radiation, 12 (4) pp. 499-505. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CC50D2291C55]

HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells

Zimmerli S. C., Harari A., Cellerai C., Vallelian F., Bart P. A., Pantaleo G., 2005/05. Proceedings of the National Academy of Sciences of the United States of America, 102 (20) pp. 7239-44.

[DOI][WoS][Pmid][serval:BIB_81FC323D58B8]

Relationship between structure and CO oxidation activity of ceria-supported gold catalysts.

Venezia A.M., Pantaleo G., Longo A., Di Carlo G., Casaletto M.P., Liotta F.L., Deganello G., 2005/02. Journal of Physical Chemistry. B, 109 (7) pp. 2821-2827. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1FC995BC8A59]

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

Harari A., Vallelian F., Meylan P.R., Pantaleo G., 2005. Journal of Immunology, 174 (2) pp. 1037-1045.

[WoS][Pmid][serval:BIB_43264304AE44]

Loss of HIV-1-specific T cell proliferation in chronic HIV-1 infection: cause or consequence of viral replication?

Lichterfeld M., Pantaleo G., Altfeld M., 2005. AIDS, 19 (11) pp. 1225-1227. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_66E66E3CB7B1]

Standardization of cytokine flow cytometry assays.

Maecker H.T., Rinfret A., D'Souza P., Darden J., Roig E., Landry C., Hayes P., Birungi J., Anzala O., Garcia M. et al., 2005. BMC Immunology, 6 p. 13. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_65F6E764F0F0]

2004

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

Pantaleo G., Koup R. A., 2004/08. Nature Medicine, 10 (8) pp. 806-10.

[DOI][WoS][Pmid][serval:BIB_1E3BBD9FBBB8]

De novo T-cell generation in patients at different ages and stages of HIV-1 disease

Nobile M., Correa R., Borghans J. A., D'Agostino C., Schneider P., De Boer R. J., Pantaleo G., 2004/07. Blood, 104 (2) pp. 470-7.

[DOI][WoS][Pmid][serval:BIB_C2DA1A717A9E]

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir

Wood R., Phanuphak P., Cahn P., Pokrovskiy V., Rozenbaum W., Pantaleo G., Sension M., Murphy R., Mancini M., Kelleher T. et al., 2004/06. Journal of Acquired Immune Deficiency Syndromes, 36 (2) pp. 684-92.

[DOI][WoS][Pmid][serval:BIB_99F8E5CE9397]

Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cells.

Balla-Jhagjhoorsingh S.S., Koopman G., Mooij P., Koornstra W., McCormack S., Weber J., Pantaleo G., Heeney J.L., 2004/04/09. AIDS, 18 (6) pp. 837-848. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9DC640B22EA7]

Pallister-Killian syndrome presenting through nuchal oedema: cytogenetic investigation and parental origin by molecular analysis in a new case

Antonella V., Pantaleo G., Anna Irma C., Savino C., Selvaggi L., 2004/03. Prenatal Diagnosis, 24 (3) pp. 229-30.

[DOI][WoS][Pmid][serval:BIB_7B69F612F7A2]

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

Harari A., Petitpierre S., Vallelian F., Pantaleo G., 2004/02. Blood, 103 (3) pp. 966-72.

[DOI][WoS][Pmid][serval:BIB_E4FE4405165A]

Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.

Didierlaurent A., Ramirez J.C., Gherardi M., Zimmerli S.C., Graf M., Orbea H.A., Pantaleo G., Wagner R., Esteban M., Kraehenbuhl J.P. et al., 2004. Vaccine, 22 (25-26) pp. 3395-403. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1885A12AD4C6]

Cytomegalovirus (CMV)-specific cellular immune responses.

Harari A., Zimmerli S.C., Pantaleo G., 2004. Human immunology, 65 (5) pp. 500-6. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9A6BACAECA40]

Functional characterization of HIV-1-specific CD4 T cells

Harari A., Pantaleo G., 2004., EPHIS book.

[serval:BIB_707312959F9D]

Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.

Harari A., Vallelian F., Pantaleo G., 2004. European journal of immunology, 34 (12) pp. 3525-33. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_67A085F19BA1]

2003

Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope

Castelli R., Tarsia P., Tantardini C., Pantaleo G., Guariglia A., Porro F., 2003/11. Vascular Medicine, 8 (4) pp. 257-61.

[DOI][WoS][Pmid][serval:BIB_9510AF8A0911]

Medicine. The need for a global HIV vaccine enterprise

Klausner R. D., Fauci A. S., Corey L., Nabel G. J., Gayle H., Berkley S., Haynes B. F., Baltimore D., Collins C., Douglas R. G. et al., 2003/06. Science, 300 (5628) pp. 2036-9.

[DOI][WoS][Pmid][serval:BIB_979C680FEC57]

Time-resolved X-ray powder diffraction on a three-way catalyst at the GILDA beamline.

Martorana A., Deganello G., Longo A., Deganello F., Liotta L., Macaluso A., Pantaleo G., Balerna A., Meneghini C., Mobilio S., 2003/03. Journal of Synchrotron Radiation, 10 (2) pp. 177-182. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_92178DF0A7A9]

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection

Mulherin S. A., O'Brien T. R., Ioannidis J. P., Goedert J. J., Buchbinder S. P., Coutinho R. A., Jamieson B. D., Meyer L., Michael N. L., Pantaleo G. et al., 2003/02. AIDS, 17 (3) pp. 377-87.

[DOI][WoS][Pmid][serval:BIB_9C992B30132D]

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Kaufmann G.R., Perrin L., Pantaleo G., Opravil M., Furrer H., Telenti A., Hirschel B., Ledergerber B., Vernazza P., Bernasconi E. et al., 2003. Archives of Internal Medicine, 163 (18) pp. 2187-2195.

[DOI][WoS][Pmid][serval:BIB_27245]

2002

Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.

Ellefsen K., Harari A., Champagne P., Bart P.A., Sékaly R.P., Pantaleo G., 2002/12. European journal of immunology, 32 (12) pp. 3756-3764. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_23749]

Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection

Harari A., Rizzardi G. P., Ellefsen K., Ciuffreda D., Champagne P., Bart P. A., Kaufmann D., Telenti A., Sahli R., Tambussi G. et al., 2002/08. Blood, 100 (4) pp. 1381-7.

[DOI][WoS][Pmid][serval:BIB_A47337CF723B]

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

Rizzardi G. P., Harari A., Capiluppi B., Tambussi G., Ellefsen K., Ciuffreda D., Champagne P., Bart P. A., Chave J. P., Lazzarin A. et al., 2002/03. Journal of Clinical Investigation, 109 (5) pp. 681-8.

[DOI][WoS][Pmid][serval:BIB_8F0AB4D335C7]

Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development.

Harari A., Ellefsen K., Champagne P., Nobile M., Pantaleo G., 2002. Advances in Experimental Medicine and Biology, 512 pp. 155-64. Peer-reviewed.

[WoS][Pmid][serval:BIB_23755]

Potential role of immune modulation in the effective long-term control of HIV-1 infection.

Rizzardi G.P., Lazzarin A., Pantaleo G., 2002. Journal of Biological Regulators and Homeostatic Agents, 16 (1) pp. 83-90. Peer-reviewed.

[WoS][Pmid][serval:BIB_23775]

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

Fellay J., Marzolini C., Meaden E.R., Back D.J., Buclin T., Chave J.P., Decosterd L.A., Furrer H., Opravil M., Pantaleo G. et al., 2002. The Lancet, 359 (9300) pp. 30-36. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_15EF32DDF0CC]

Transepithelial transport of HIV-1 by M cells is receptor-mediated.

Fotopoulos G., Harari A., Michetti P., Trono D., Pantaleo G., Kraehenbuhl J.P., 2002. Proceedings of the National Academy of Sciences of the United States of America, 99 (14) pp. 9410-4. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7F4A301E9B37]

2001

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data

Ioannidis J. P., Rosenberg P. S., Goedert J. J., Ashton L. J., Benfield T. L., Buchbinder S. P., Coutinho R. A., Eugen-Olsen J., Gallart T., Katzenstein T. L. et al., 2001/11. Annals of Internal Medicine, 135 (9) pp. 782-95.

[WoS][Pmid][serval:BIB_BCAFDA0D82B2]

Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

Peter K., Men Y., Pantaleo G., Gander B., Corradin G., 2001/07. Vaccine, 19 (30) pp. 4121-9.

[DOI][WoS][Pmid][serval:BIB_347FD9650034]

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

Garcia F., Plana M., Ortiz G. M., Bonhoeffer S., Soriano A., Vidal C., Cruceta A., Arnedo M., Gil C., Pantaleo G. et al., 2001/06. AIDS, 15 (9) pp. F29-40.

[DOI][WoS][Pmid][serval:BIB_1302C932390F]

Skewed maturation of memory HIV-specific CD8 T lymphocytes

Champagne P., Ogg G. S., King A. S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G. P., Fleury S., Lipp M. et al., 2001/03. Nature, 410 (6824) pp. 106-11.

[DOI][WoS][Pmid][serval:BIB_CB67746EE255]

Cytotoxic T-cell responses in acute and chronic HIV-1 infection

Soudeyns H., Pantaleo G., 2001. p. 213 dans Pantaleo G., Walker B.D. (eds.) Retroviral Immunology chap. 9, Springer-Verlag.

[serval:BIB_5657FF08ADE5]

Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.

Bart P.A., Rizzardi P.G., Gallant S., Golay K.P., Baumann P., Pantaleo G., Eap C.B., 2001. Therapeutic drug monitoring, 23 (5) pp. 553-5. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_5E69B13DE248]

Pathogenesis of HIV-1 infection

Rizzardi G. P., Pantaleo G., 2001. 51-74.

[serval:BIB_09C76A505D9B]

2000

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count

Rizzardi G. P., Tambussi G., Bart P. A., Chapuis A. G., Lazzarin A., Pantaleo G., 2000/10. AIDS, 14 (15) pp. 2257-63.

[DOI][WoS][Pmid][serval:BIB_1BCA2AEDCDC7]

Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection

Brambilla A., Villa C., Rizzardi G., Veglia F., Ghezzi S., Lazzarin A., Cusini M., Muratori S., Santagostino E., Gringeri A. et al., 2000/07. Journal of Infectious Diseases, 182 (1) pp. 311-5.

[URN][DOI][WoS][Pmid][serval:BIB_15251431BF3D]

Cyclosporin A in combination with HAART in primary HIV-1 infection

Rizzardi G. P., Vaccarezza M., Capiluppi B., Tambussi G., Lazzarin A., Pantaleo G., 2000/03. Journal of Biological Regulators and Homeostatic Agents, 14 (1) pp. 79-81.

[WoS][Pmid][serval:BIB_F4228C39B108]

Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality

Soudeyns H., Campi G., Rizzardi G. P., Lenge C., Demarest J. F., Tambussi G., Lazzarin A., Kaufmann D., Casorati G., Corey L. et al., 2000/03. Blood, 95 (5) pp. 1743-51.

[WoS][Pmid][serval:BIB_9BF24D6C52A7]

Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA

Rizzardi G. P., De Boer R. J., Hoover S., Tambussi G., Chapuis A., Halkic N., Bart P. A., Miller V., Staszewski S., Notermans D. W. et al., 2000/03. Journal of Clinical Investigation, 105 (6) pp. 777-82. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D4C4AC55EE07]

Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study

Burgisser P., Vernazza P., Flepp M., Boni J., Tomasik Z., Hummel U., Pantaleo G., Schupbach J., 2000/02. Journal of Acquired Immune Deficiency Syndromes, 23 (2) pp. 138-44.

[WoS][Pmid][serval:BIB_38A276F2AF1E]

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo.

Chapuis A.G., Paolo Rizzardi G., D'Agostino C., Attinger A., Knabenhans C., Fleury S., Acha-Orbea H., Pantaleo G., 2000. Nature Medicine, 6 (7) pp. 762-768. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_15103]

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.

Bart P.A., Rizzardi G.P., Tambussi G., Chave J.P., Chapuis A.G., Graziosi C., Corpataux J.M., Halkic N., Meuwly J.Y., Munoz M. et al., 2000. AIDS, 14 (13) pp. 1887-1897. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_93716372A45C]

La Vaccination Cellulaire

Champagne P., Pantaleo G., 2000. Medecine et Hygiène, 58 pp. 989-991.

[serval:BIB_30E17A6EC7FA]

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.

Fleury S., Rizzardi G.P., Chapuis A., Tambussi G., Knabenhans C., Simeoni E., Meuwly J.Y., Corpataux J.M., Lazzarin A., Miedema F. et al., 2000. Proceedings of the National Academy of Sciences of the United States of America, 97 (10) pp. 5393-5398. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CFE4DBFE5531]

1999

Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope

Soudeyns H., Paolucci S., Chappey C., Daucher M. B., Graziosi C., Vaccarezza M., Cohen O. J., Fauci A. S., Pantaleo G., 1999/11. European Journal of Immunology, 29 (11) pp. 3629-35.

[DOI][WoS][Pmid][serval:BIB_52915D0A12BA]

The moving target: mechanisms of HIV persistence during primary infection

Soudeyns H., Pantaleo G., 1999/10. Immunology Today, 20 (10) pp. 446-50.

[DOI][WoS][Pmid][serval:BIB_8EAB6ADEEE2D]

Therapeutic perspectives in HIV-1 infection from recent advances in HIV-1 pathogenesis: it is time to move on

Rizzardi G. P., Pantaleo G., 1999/09. Journal of Biological Regulators and Homeostatic Agents, 13 (3) pp. 151-7.

[WoS][Pmid][serval:BIB_497FE60E2E48]

Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study

Bart P. A., Meuwly J. Y., Corpataux J. M., Yerly S., Rizzardi P., Fleury S., Munoz M., Knabenhans C., Welbon C., Pantaleo G. et al., 1999/08. AIDS, 13 (12) pp. 1503-9.

[DOI][WoS][Pmid][serval:BIB_AF023E65D591]

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

Garcia F., Plana M., Vidal C., Cruceta A., O'Brien W. A., Pantaleo G., Pumarola T., Gallart T., Miro J. M., Gatell J. M., 1999/07. AIDS, 13 (11) pp. F79-86.

[DOI][WoS][Pmid][serval:BIB_D75BAD26630D]

T cell regeneration in HIV-infected subjects under highly active antiretroviral therapy (review)

Fleury S., Pantaleo G., 1999/07. International Journal of Molecular Medicine, 4 (1) pp. 91-7.

[WoS][Pmid][serval:BIB_F1B50FB6E67E]

Unraveling the strands of HIV's web

Pantaleo G., 1999/01. Nature Medicine, 5 (1) pp. 27-8.

[DOI][WoS][Pmid][serval:BIB_5DD7548A41B7]

1998

Immunopathogenesis of HIV infection

Graziosi C., Soudeyns H., Rizzardi G. P., Bart P. A., Chapuis A., Pantaleo G., 1998/06. AIDS Research and Human Retroviruses, 14 Suppl 2 pp. S135-42.

[WoS][Pmid][serval:BIB_A974D2764559]

Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy

Perrin L., Yerly S., Marchal F., Schockmel G. A., Hirschel B., Fox C. H., Pantaleo G., 1998/06. Journal of Infectious Diseases, 177 (6) pp. 1497-501.

[URN][DOI][WoS][Pmid][serval:BIB_24FEFC536E15]

CCR2 polymorphism and HIV disease. Swiss HIV Cohort

Rizzardi G. P., Morawetz R. A., Vicenzi E., Ghezzi S., Poli G., Lazzarin A., Pantaleo G., 1998/03. Nature Medicine, 4 (3) pp. 252-3.

[DOI][WoS][Pmid][serval:BIB_9F3A5F960F62]

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

Kaufmann D., Pantaleo G., Sudre P., Telenti A., 1998/03. Lancet, 351 (9104) pp. 723-4.

[DOI][WoS][Pmid][serval:BIB_6B668C183A88]

Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy

Pantaleo G., Cohen O. J., Schacker T., Vaccarezza M., Graziosi C., Rizzardi G. P., Kahn J., Fox C. H., Schnittman S. M., Schwartz D. H. et al., 1998/03. Nature Medicine, 4 (3) pp. 341-5.

[DOI][WoS][Pmid][serval:BIB_9CAF08C41018]

Analysis of virologic and immunologic events in HIV infection

Graziosi C., Pantaleo G., 1998. Pathobiology, 66 (3-4) pp. 123-7.

[DOI][WoS][Pmid][serval:BIB_D1F900588800]

Can HIV be eradicated?

Pantaleo G., Perrin L., 1998. AIDS, 12 Suppl A pp. S175-80.

[Pmid][serval:BIB_F518454E2C19]

Impact des nouveaux concepts pathogéniques de l'infection VIH sur les perspectives thérapeutiques [Impact of new concepts in pathogenesis of HIV infection on future therapeutic perspectives]

Bart P.A., Pantaleo G., 1998. Médecine et Hygiène, 56 (2215) pp. 1374-1377.

[serval:BIB_BE1933356971]

Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.

Fleury S., de Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., Graziosi C., Knabenhans C., Soudeyns H., Bart P.A. et al., 1998. Nature Medicine, 4 (7) pp. 794-801. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B77754D94784]

1997

The multi-faceted personality of HIV

Graziosi C., Pantaleo G., 1997/12. Nature Medicine, 3 (12) pp. 1318-20.

[DOI][WoS][Pmid][serval:BIB_5BAC03C437B0]

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

Pilgrim A. K., Pantaleo G., Cohen O. J., Fink L. M., Zhou J. Y., Zhou J. T., Bolognesi D. P., Fauci A. S., Montefiori D. C., 1997/10. Journal of Infectious Diseases, 176 (4) pp. 924-32.

[URN][DOI][WoS][Pmid][serval:BIB_B052FDB18CA6]

Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection

Pantaleo G., Soudeyns H., Demarest J. F., Vaccarezza M., Graziosi C., Paolucci S., Daucher M., Cohen O. J., Denis F., Biddison W. E. et al., 1997/09. Proceedings of the National Academy of Sciences of the United States of America, 94 (18) pp. 9848-53.

[DOI][WoS][Pmid][serval:BIB_CFC8A44EECCC]

Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors

Cohen O. J., Vaccarezza M., Lam G. K., Baird B. F., Wildt K., Murphy P. M., Zimmerman P. A., Nutman T. B., Fox C. H., Hoover S. et al., 1997/09. Journal of Clinical Investigation, 100 (6) pp. 1581-9.

[DOI][WoS][Pmid][serval:BIB_46BE7661B3AE]

Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys

Martin L. N., Murphey-Corb M., Mack P., Baskin G. B., Pantaleo G., Vaccarezza M., Fox C. H., Fauci A. S., 1997/08. Journal of Infectious Diseases, 176 (2) pp. 374-83.

[DOI][WoS][Pmid][serval:BIB_32823A4329E0]

Immunology of HIV infection

Pantaleo G., 1997/08. Research in Immunology, 148 (6) pp. 417-9.

[DOI][WoS][Pmid][serval:BIB_77931026C73E]

New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection

Soudeyns H., Pantaleo G., 1997/06. Journal of Biological Regulators and Homeostatic Agents, 11 (1-2) pp. 37-9.

[WoS][Pmid][serval:BIB_189901F3B08D]

Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy

Rizzardi G. P., Tambussi G., Barcellini W., Capiluppi B., Clerici E., Maestra L. L., Lillo F., Pantaleo G., Lazzarin A., 1997/06. Journal of Biological Regulators and Homeostatic Agents, 11 (1-2) pp. 43-9.

[WoS][Pmid][serval:BIB_357101EFC6E8]

How immune-based interventions can change HIV therapy

Pantaleo G., 1997/05. Nature Medicine, 3 (5) pp. 483-6.

[DOI][WoS][Pmid][serval:BIB_4C8538DD5AC1]

Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.

Pantaleo G., Soudeyns H., Demarest J.F., Vaccarezza M., Graziosi C., Paolucci S., Daucher M.B., Cohen O.J., Denis F., Biddison W.E. et al., 1997. European journal of immunology, 27 (12) pp. 3166-73. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_60FFCF1F24A3]

Activated cytotoxic lymphocytes in lymph nodes from human immunodeficiency virus (HIV) 1-infected patients: a light and electronmicroscopic study

Sunila I., Vaccarezza M., Pantaleo G., Fauci A. S., Orenstein J. M., 1997/01. Histopathology, 30 (1) pp. 31-40.

[DOI][WoS][Pmid][serval:BIB_C490963B1C9B]

Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.

Morawetz R.A., Rizzardi G.P., Glauser D., Rutschmann O., Hirschel B., Perrin L., Opravil M., Flepp M., von Overbeck J., Glauser M.P. et al., 1997. European journal of immunology, 27 (12) pp. 3223-7. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F73ADE6E5C58]

gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: an immunoelectron microscopic study

Sunila I., Vaccarezza M., Pantaleo G., Fauci A. S., Orenstein J. M., 1997/01. AIDS, 11 (1) pp. 27-32.

[WoS][Pmid][serval:BIB_8FF0FDD7D03D]

Introduction: recent advances in the pathogenesis of human immunodeficiency virus infection.

Pantaleo G., Fauci A.S., 1997. Springer seminars in immunopathology, 18 (3) pp. 253-256. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8E073EC3A132]

Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies

Cohen O. J., Pantaleo G., Lam G. K., Fauci A. S., 1997. Springer Seminars in Immunopathology, 18 (3) pp. 305-22.

[DOI][WoS][Pmid][serval:BIB_8AFBCB677B77]

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

Pantaleo G., Demarest J. F., Schacker T., Vaccarezza M., Cohen O. J., Daucher M., Graziosi C., Schnittman S. S., Quinn T. C., Shaw G. M. et al., 1997/01. Proceedings of the National Academy of Sciences of the United States of America, 94 (1) pp. 254-8.

[DOI][WoS][Pmid][serval:BIB_324D123634C8]

Virologic and immunologic events in primary HIV infection

Pantaleo G., Graziosi C., Fauci A. S., 1997. Springer Seminars in Immunopathology, 18 (3) pp. 257-66.

[DOI][WoS][Pmid][serval:BIB_7177531592A5]

1996

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

Mingari M. C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A. S., Moretta L., 1996/10. Proceedings of the National Academy of Sciences of the United States of America, 93 (22) pp. 12433-8.

[DOI][WoS][Pmid][serval:BIB_F16B2BFC6581]

Response: HIV Quasispecies and Resampling

Haynes B. F., Pantaleo G., Fauci A. S., 1996/07. Science, 273 (5274) pp. 416a.

[DOI][Pmid][serval:BIB_6D7742226ECA]

Response: Correlates of Protective Viruses Damaging to HIV Infection

Haynes B. F., Pantaleo G., Fauci A. S., 1996/05. Science, 272 (5266) pp. 1362b.

[DOI][WoS][Pmid][serval:BIB_F70E82EB0249]

Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes

Cohen O. J., Pantaleo G., Holodniy M., Fox C. H., Orenstein J. M., Schnittman S., Niu M., Graziosi C., Pavlakis G. N., Lalezari J. et al., 1996/04. Journal of Infectious Diseases, 173 (4) pp. 849-56.

[WoS][Pmid][serval:BIB_BFB8C5543009]

Immunopathogenic mechanisms of HIV infection

Fauci A. S., Pantaleo G., Stanley S., Weissman D., 1996/04. Annals of Internal Medicine, 124 (7) pp. 654-63.

[WoS][Pmid][serval:BIB_8F38BB211D5A]

Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection

Graziosi C., Gantt K. R., Vaccarezza M., Demarest J. F., Daucher M., Saag M. S., Shaw G. M., Quinn T. C., Cohen O. J., Welbon C. C. et al., 1996/04. Proceedings of the National Academy of Sciences of the United States of America, 93 (9) pp. 4386-91.

[DOI][WoS][Pmid][serval:BIB_0101B41AE49B]

Antiviral Immunity in HIV-1 infected long term non-progressors (LTNPs).

Pantaleo G, Vaccarezza M, Graziosi C, Cohen OJ, Fauci AS, 1996. Seminars in Virology, 7 (2) pp. 131-138.

[WoS][serval:BIB_563B016FEAEB]

Immunopathogenesis of HIV infection

Pantaleo G., Fauci A. S., 1996. Annual Review of Microbiology, 50 pp. 825-54.

[DOI][WoS][Pmid][serval:BIB_7B31A2882866]

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

Montefiori D. C., Pantaleo G., Fink L. M., Zhou J. T., Zhou J. Y., Bilska M., Miralles G. D., Fauci A. S., 1996/01. Journal of Infectious Diseases, 173 (1) pp. 60-7.

[DOI][WoS][Pmid][serval:BIB_D7FB7052C4A5]

Toward an understanding of the correlates of protective immunity to HIV infection

Haynes B. F., Pantaleo G., Fauci A. S., 1996/01. Science, 271 (5247) pp. 324-8.

[DOI][WoS][Pmid][serval:BIB_0273EF843115]

1995

New concepts in the immunopathogenesis of HIV infection

Graziosi C., Pantaleo G., 1995/09. Journal of Biological Regulators and Homeostatic Agents, 9 (3) pp. 73-5.

[WoS][Pmid][serval:BIB_0243D0BF7320]

Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue

Cohen O. J., Pantaleo G., Holodniy M., Schnittman S., Niu M., Graziosi C., Pavlakis G. N., Lalezari J., Bartlett J. A., Steigbigel R. T. et al., 1995/06. Proceedings of the National Academy of Sciences of the United States of America, 92 (13) pp. 6017-21.

[DOI][WoS][Pmid][serval:BIB_E9BF88CBC47A]

Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden

Muro-Cacho C. A., Pantaleo G., Fauci A. S., 1995/05. Journal of Immunology, 154 (10) pp. 5555-66.

[WoS][Pmid][serval:BIB_04BD8C5E4C5A]

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

Koenig S., Conley A. J., Brewah Y. A., Jones G. M., Leath S., Boots L. J., Davey V., Pantaleo G., Demarest J. F., Carter C. et al., 1995/04. Nature Medicine, 1 (4) pp. 330-6.

[DOI][WoS][Pmid][serval:BIB_F45E6EE5EAE3]

Apoptosis in HIV infection

Pantaleo G., Fauci A. S., 1995/02. Nature Medicine, 1 (2) pp. 118-20.

[DOI][WoS][Pmid][serval:BIB_808E6C7CAFF4]

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission

Pantaleo G., Demarest J. F., Vaccarezza M., Graziosi C., Bansal G. P., Koenig S., Fauci A. S., 1995/01. European Journal of Immunology, 25 (1) pp. 226-31.

[DOI][WoS][Pmid][serval:BIB_9B8C105D7D51]

New concepts in the immunopathogenesis of HIV infection

Pantaleo G., Fauci A. S., 1995. Annual Review of Immunology, 13 pp. 487-512.

[DOI][WoS][Pmid][serval:BIB_1BF7FE15F444]

Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals

Cohen O. J., Pantaleo G., Schwartzentruber D. J., Graziosi C., Vaccarezza M., Fauci A. S., 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10 Suppl 1 pp. S6-14.

[Pmid][serval:BIB_B588BF395741]

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O. J., Demarest J. F., Montefiori D., Orenstein J. M., Fox C., Schrager L. K. et al., 1995/01. New England Journal of Medicine, 332 (4) pp. 209-16.

[DOI][WoS][Pmid][serval:BIB_E6DDE35DAC62]

1994

Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals

Graziosi C., Pantaleo G., Fauci A. S., 1994/12. Research in Immunology, 145 (8-9) pp. 602-5; discussion 605-7.

[DOI][WoS][Pmid][serval:BIB_215B49959426]

Expression of a wide T cell receptor V beta repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors

Poggi A., Demarest J. F., Costa P., Biassoni R., Pella N., Pantaleo G., Mingari M. C., Moretta L., 1994/09. European Journal of Immunology, 24 (9) pp. 2258-61.

[DOI][WoS][Pmid][serval:BIB_ABF4A12A318F]

Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule 1 in human immunodeficiency virus-mediated syncytia formation

Butini L., De Fougerolles A. R., Vaccarezza M., Graziosi C., Cohen D. I., Montroni M., Springer T. A., Pantaleo G., Fauci A. S., 1994/09. European Journal of Immunology, 24 (9) pp. 2191-5.

[DOI][WoS][Pmid][serval:BIB_8294B44F4F80]

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV

Pantaleo G., Demarest J. F., Soudeyns H., Graziosi C., Denis F., Adelsberger J. W., Borrow P., Saag M. S., Shaw G. M., Sekaly R. P. et al., 1994/08. Nature, 370 (6489) pp. 463-7.

[DOI][WoS][Pmid][serval:BIB_3F0888547271]

Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection

Pantaleo G., Graziosi C., Demarest J. F., Cohen O. J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A. S., 1994/08. Immunological Reviews, 140 pp. 105-30.

[DOI][WoS][Pmid][serval:BIB_35ABD321469C]

Tracking HIV during disease progression

Pantaleo G., Fauci A. S., 1994/08. Current Opinion in Immunology, 6 (4) pp. 600-4.

[DOI][WoS][Pmid][serval:BIB_F1342035F3BC]

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sekaly R. P., Fauci A. S., 1994/07. Science, 265 (5169) pp. 248-52.

[DOI][WoS][Pmid][serval:BIB_13E38F10C5DA]

Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins

Rebai N., Pantaleo G., Demarest J. F., Ciurli C., Soudeyns H., Adelsberger J. W., Vaccarezza M., Walker R. E., Sekaly R. P., Fauci A. S., 1994/02. Proceedings of the National Academy of Sciences of the United States of America, 91 (4) pp. 1529-33.

[DOI][WoS][Pmid][serval:BIB_C76F828E2617]

1993

HIV-1 infection in the lymphoid organs

Graziosi C., Pantaleo G., Demarest J. F., Cohen O. J., Vaccarezza M., Butini L., Montroni M., Fauci A. S., 1993/11. AIDS, 7 Suppl 2 pp. S53-8.

[DOI][WoS][Pmid][serval:BIB_65B7BB906C1B]

Immunopathogenesis of human immunodeficiency virus infection

Poli G., Pantaleo G., Fauci A. S., 1993/08. Clinical Infectious Diseases, 17 Suppl 1 pp. S224-9.

[WoS][Pmid][serval:BIB_046DDFBA62A2]

Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection

Graziosi C., Pantaleo G., Butini L., Demarest J. F., Saag M. S., Shaw G. M., Fauci A. S., 1993/07. Proceedings of the National Academy of Sciences of the United States of America, 90 (14) pp. 6405-9.

[DOI][WoS][Pmid][serval:BIB_41DE395FADF6]

The role of lymphoid organs in the pathogenesis of HIV infection

Pantaleo G., Graziosi C., Fauci A. S., 1993/06. Seminars in Immunology, 5 (3) pp. 157-63.

[DOI][Pmid][serval:BIB_E2456F0E8016]

The T cell receptor V beta repertoire in HIV-1 infection and disease

Soudeyns H., Rebai N., Pantaleo G. P., Ciurli C., Boghossian T., Sekaly R. P., Fauci A. S., 1993/06. Seminars in Immunology, 5 (3) pp. 175-85.

[DOI][Pmid][serval:BIB_BB3F13EDA58D]

The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism

Dayton E. T., Konings D. A., Lim S. Y., Hsu R. K., Butini L., Pantaleo G., Dayton A. I., 1993/05. Journal of Virology, 67 (5) pp. 2871-8.

[WoS][Pmid][serval:BIB_36374A6A9689]

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S., 1993/03. Nature, 362 (6418) pp. 355-8.

[DOI][WoS][Pmid][serval:BIB_B62C0A9BDED5]

New concepts in the immunopathogenesis of human immunodeficiency virus infection

Pantaleo G., Graziosi C., Fauci A. S., 1993/02. New England Journal of Medicine, 328 (5) pp. 327-35.

[DOI][WoS][Pmid][serval:BIB_4262F0784F81]

Brain mapping: a contribution to linear interpolation

Casaglia D. C., Pantaleo G. G., 1993. Brain Topography, 5 (3) pp. 283-8.

[Pmid][serval:BIB_3D984D83AA90]

The role of lymphoid organs in the immunopathogenesis of HIV infection

Pantaleo G., Graziosi C., Fauci A. S., 1993. AIDS, 7 Suppl 1 pp. S19-23.

[DOI][WoS][Pmid][serval:BIB_AABC01DA058C]

1991

Lymphoid organs function as major reservoirs for human immunodeficiency virus

Pantaleo G., Graziosi C., Butini L., Pizzo P. A., Schnittman S. M., Kotler D. P., Fauci A. S., 1991/11. Proceedings of the National Academy of Sciences of the United States of America, 88 (21) pp. 9838-42.

[DOI][WoS][Pmid][serval:BIB_9ECE53A5D110]

Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes

Bressler P., Pantaleo G., Demaria A., Fauci A. S., 1991/10. Journal of Immunology, 147 (7) pp. 2290-4.

[WoS][Pmid][serval:BIB_99BA8179E536]

Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection

Pantaleo G., Poli G., Butini L., Fox C., Dayton A. I., Fauci A. S., 1991/07. European Journal of Immunology, 21 (7) pp. 1771-4.

[DOI][WoS][Pmid][serval:BIB_7B20D6845178]

Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells

De Maria A., Pantaleo G., Schnittman S. M., Greenhouse J. J., Baseler M., Orenstein J. M., Fauci A. S., 1991/04. Journal of Immunology, 146 (7) pp. 2220-6.

[WoS][Pmid][serval:BIB_58AE6E1B4938]

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

Fauci A. S., Schnittman S. M., Poli G., Koenig S., Pantaleo G., 1991/04. Annals of Internal Medicine, 114 (8) pp. 678-93.

[WoS][Pmid][serval:BIB_24C6D8C6BE22]

Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission

Pantaleo G., Butini L., Graziosi C., Poli G., Schnittman S. M., Greenhouse J. J., Gallin J. I., Fauci A. S., 1991/02. Journal of Experimental Medicine, 173 (2) pp. 511-4.

[DOI][WoS][Pmid][serval:BIB_FFB433AD725A]

1990

CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity

Pantaleo G., De Maria A., Koenig S., Butini L., Moss B., Baseler M., Lane H. C., Fauci A. S., 1990/06. Proceedings of the National Academy of Sciences of the United States of America, 87 (12) pp. 4818-22.

[DOI][WoS][Pmid][serval:BIB_6C989B92C868]

A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function

Moretta A., Tambussi G., Bottino C., Tripodi G., Merli A., Ciccone E., Pantaleo G., Moretta L., 1990/03. Journal of Experimental Medicine, 171 (3) pp. 695-714.

[DOI][WoS][Pmid][serval:BIB_95A5FFD38DD6]

Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population

Pantaleo G., Koenig S., Baseler M., Lane H. C., Fauci A. S., 1990/03. Journal of Immunology, 144 (5) pp. 1696-704.

[WoS][Pmid][serval:BIB_B580D65822A7]

1989

Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans

Moretta A., Ciccone E., Pantaleo G., Tambussi G., Bottino C., Melioli G., Mingari M. C., Moretta L., 1989/10. Immunological Reviews, 111 pp. 145-75.

[DOI][WoS][Pmid][serval:BIB_630230147FD7]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition